Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ACKR1 CCBP1, CD234, DARC, Dfy, FY, GPD ENSG00000213088 Atypical chemokine receptor 1 (Duffy blood group) 1 159203307-159206500 Blood group antigen proteins, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA016421, HPA017672 Supported Mixed adipose tissue: 111.8 ACKR2 CCBP2, CCR10, CCR9, CMKBR9, D6 ENSG00000144648 Atypical chemokine receptor 2 3 42804752-42887974 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013819, HPA073493 Supported Supported Nucleoplasm
Vesicles
Cytosol Tissue enhanced 0 placenta: 22.8 adipose tissue: 5.2 ACKR3 CMKOR1, CXCR7, GPR159, RDC1 ENSG00000144476 Atypical chemokine receptor 3 2 236567787-236582358 Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032003, HPA049718 Approved Supported Vesicles
Plasma membrane Expressed in all placenta: 175.2 ACKR4 CCBP2, CCR11, CCRL1, CCX-CKR, PPR1, VSHK1 ENSG00000129048 Atypical chemokine receptor 4 3 132597237-132618967 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA027595 Uncertain Cytosol Mixed duodenum: 19.7 ADCYAP1R1 PAC1, PAC1R, PACAPR ENSG00000078549 Adenylate cyclase activating polypeptide 1 (pituitary) receptor type I 7 31052461-31111479 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA049877 Approved Uncertain Vesicles Tissue enhanced 0 cerebral cortex: 137.5;fallopian tube: 46.5 cervix: 20.6 ADGRA1 GPR123, KIAA1828 ENSG00000197177 Adhesion G protein-coupled receptor A1 10 133070929-133131675 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA042773 Approved Tissue enhanced 0 adrenal gland: 4.9;cerebral cortex: 22.5 fallopian tube: 3.1 ADGRA2 DKFZp434C211, DKFZp434J0911, FLJ14390, GPR124, KIAA1531, TEM5 ENSG00000020181 Adhesion G protein-coupled receptor A2 8 37784191-37844896 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012393 Uncertain Expressed in all seminal vesicle: 86.1 ADGRA3 FLJ38547, GPR125, PGR21 ENSG00000152990 Adhesion G protein-coupled receptor A3 4 22345071-22516054 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA008904 Uncertain Expressed in all thyroid gland: 42.3 ADGRB1 BAI1 ENSG00000181790 Adhesion G protein-coupled receptor B1 8 142449430-142545009 Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 9 cerebral cortex: 22.0 spleen: 2.3 ADGRB2 BAI2 ENSG00000121753 Adhesion G protein-coupled receptor B2 1 31727117-31764893 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052612, HPA054617 Supported Centrosome Tissue enriched 14 cerebral cortex: 72.5 adrenal gland: 5.1 ADGRB3 BAI3, KIAA0550 ENSG00000135298 Adhesion G protein-coupled receptor B3 6 68635367-69389511 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 10 cerebral cortex: 53.2 adrenal gland: 5.2 ADGRD1 DKFZp434B1272, GPR133, PGR25 ENSG00000111452 Adhesion G protein-coupled receptor D1 12 130953907-131141469 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042395 Uncertain Approved Nucleus
Cytosol Tissue enhanced 0 placenta: 44.3 lung: 32.7 ADGRD2 GPR144, PGR24 ENSG00000180264 Adhesion G protein-coupled receptor D2 9 124451600-124478589 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 epididymis: 2.3;seminal vesicle: 5.6 breast: 1.4 ADGRE1 EMR1, TM7LN3 ENSG00000174837 Adhesion G protein-coupled receptor E1 19 6887566-6940459 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052809 Uncertain Tissue enhanced 0 appendix: 10.2;spleen: 20.1 lung: 6.8 ADGRE2 CD312, EMR2 ENSG00000127507 Adhesion G protein-coupled receptor E2 19 14732393-14778541 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA055200 Uncertain Vesicles Tissue enhanced 0 appendix: 27.6;spleen: 15.7 adipose tissue: 5.9 ADGRE3 EMR3 ENSG00000131355 Adhesion G protein-coupled receptor E3 19 14619117-14690027 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA015638 Uncertain Tissue enhanced 0 appendix: 8.9;spleen: 8.8 lung: 3.9 ADGRE5 CD97, TM7LN1 ENSG00000123146 Adhesion G protein-coupled receptor E5 19 14380501-14408725 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013707 Supported Approved Cytosol Expressed in all spleen: 142.8 ADGRF1 GPR110, hGPCR36, PGR19 ENSG00000153292 Adhesion G protein-coupled receptor F1 6 46997703-47042363 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA038438 Approved Tissue enhanced 0 esophagus: 14.7;kidney: 17.6;urinary bladder: 19.6 gallbladder: 9.5 ADGRF2 GPR111, hGPCR35, PGR20 ENSG00000164393 Adhesion G protein-coupled receptor F2 6 47656436-47697797 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035507 Uncertain Tissue enhanced 0 fallopian tube: 1.5;skin: 1.4 esophagus: 0.3 ADGRF3 GPR113, hGPCR37, PGR23 ENSG00000173567 Adhesion G protein-coupled receptor F3 2 26308173-26346817 G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044500 Uncertain Not detected kidney: 0.9 ADGRF4 FLJ38076, GPR115, PGR18 ENSG00000153294 Adhesion G protein-coupled receptor F4 6 47685864-47722021 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA007131, HPA007158 Supported Uncertain Mitochondria Group enriched 7 esophagus: 12.1;skin: 45.9 tonsil: 3.9 ADGRF5 DKFZp564O1923, GPR116, KIAA0758 ENSG00000069122 Adhesion G protein-coupled receptor F5 6 46852512-46954943 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lung: 158.0 adipose tissue: 76.0 ADGRG1 GPR56, TM7LN4, TM7XN1 ENSG00000205336 Adhesion G protein-coupled receptor G1 16 57610652-57665580 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA046065 Uncertain Expressed in all thyroid gland: 348.2 ADGRG2 EDDM6, GPR64, HE6, TM7LN2 ENSG00000173698 Adhesion G protein-coupled receptor G2 X 18989309-19122637 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001478, HPA050029 Supported Approved Plasma membrane
Cytosol Tissue enriched 6 epididymis: 1469.4 parathyroid gland: 235.5 ADGRG3 GPR97, Pb99, PGR26 ENSG00000182885 Adhesion G protein-coupled receptor G3 16 57668187-57689378 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA040469 Uncertain Group enriched 5 appendix: 19.4;bone marrow: 86.7 adipose tissue: 9.6 ADGRG4 GPR112, PGR17, RP1-299I16 ENSG00000156920 Adhesion G protein-coupled receptor G4 X 136300963-136416888 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA035324 Uncertain Tissue enhanced 0 duodenum: 2.6;small intestine: 1.7 fallopian tube: 0.5 ADGRG5 GPR114, PGR27 ENSG00000159618 Adhesion G protein-coupled receptor G5 16 57542421-57591681 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA007133 Supported Approved Nucleoplasm
Nuclear membrane
Vesicles Tissue enhanced 0 lymph node: 11.3;tonsil: 8.9 appendix: 6.2 ADGRG6 FLJ14937, GPR126 ENSG00000112414 Adhesion G protein-coupled receptor G6 6 142301854-142446266 G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017346 Approved Tissue enhanced 0 placenta: 66.6 liver: 36.9 ADGRG7 FLJ14454, GPR128 ENSG00000144820 Adhesion G protein-coupled receptor G7 3 100609589-100695479 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 6 duodenum: 44.0;liver: 12.4;small intestine: 43.8 colon: 5.4 ADGRL1 CIRL1, KIAA0821, LEC2, LPHN1 ENSG00000072071 Adhesion G protein-coupled receptor L1 19 14147743-14206187 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA037974 Uncertain Tissue enhanced 0 cerebral cortex: 60.3 parathyroid gland: 24.2 ADGRL2 KIAA0786, LEC1, LPHH1, LPHN2 ENSG00000117114 Adhesion G protein-coupled receptor L2 1 81306160-81992436 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA043447 Approved Plasma membrane
Cell Junctions Mixed thyroid gland: 72.8 ADGRL3 KIAA0768, LEC3, LPHN3 ENSG00000150471 Adhesion G protein-coupled receptor L3 4 61201258-62078335 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015027, HPA015762, CAB022698 Uncertain Tissue enhanced 0 cerebral cortex: 42.1;parathyroid gland: 30.1 cervix: 8.5 ADGRL4 ELTD1, ETL ENSG00000162618 Adhesion G protein-coupled receptor L4 1 78889764-79006718 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA025229 Supported Mixed adipose tissue: 67.6 ADGRV1 DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1 ENSG00000164199 Adhesion G protein-coupled receptor V1 5 90529344-91164221 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA067503 Approved Group enriched 6 adrenal gland: 56.5;cerebral cortex: 29.1 thyroid gland: 6.6 ADORA1 RDC7 ENSG00000163485 Adenosine A1 receptor 1 203090654-203167405 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044383 Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 46.5;testis: 23.4 parathyroid gland: 17.5 ADORA2A ADORA2, RDC8 ENSG00000128271 Adenosine A2a receptor 22 24417879-24442360 Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 bone marrow: 9.6 lymph node: 7.7 ADORA2B ENSG00000170425 Adenosine A2b receptor 17 15944917-15975746 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA073747 Uncertain Cytosol Mixed colon: 8.3 ADORA3 AD026 ENSG00000282608 Adenosine A3 receptor 1 111499429-111503760 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Mixed adrenal gland: 18.5 ADRA1A ADRA1C, ADRA1L1 ENSG00000120907 Adrenoceptor alpha 1A 8 26748150-26867273 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029678, HPA029679 Approved Tissue enhanced 0 adipose tissue: 22.6;liver: 32.0 seminal vesicle: 19.5 ADRA1B ENSG00000170214 Adrenoceptor alpha 1B 5 159916783-159972544 Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA074416 Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 14.8;spleen: 17.3 ovary: 4.8 ADRA1D ADRA1, ADRA1A, ADRA1R ENSG00000171873 Adrenoceptor alpha 1D 20 4220631-4249074 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA038789 Uncertain Tissue enhanced 0 cervix, uterine: 4.3;prostate: 4.2 seminal vesicle: 2.5 ADRA2A ADRA2, ADRA2R, ADRAR ENSG00000150594 Adrenoceptor alpha 2A 10 111077163-111080907 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed cervix: 33.1 ADRA2C ADRA2L2, ADRA2RL2, ADRARL2 ENSG00000184160 Adrenoceptor alpha 2C 4 3766348-3768526 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA057688 Uncertain Tissue enhanced 0 cervix, uterine: 21.0;endometrium: 26.0;seminal vesicle: 26.7 fallopian tube: 7.9 ADRB1 ADRB1R ENSG00000043591 Adrenoceptor beta 1 10 114044056-114046908 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA067972 Supported Tissue enhanced 0 placenta: 45.2 heart muscle: 11.9 ADRB2 ADRB2R, ADRBR, B2AR, BAR ENSG00000169252 Adrenoceptor beta 2, surface 5 148825245-148828687 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003431, HPA075322 Uncertain Uncertain Cytosol Mixed lung: 16.3 ADRB3 ENSG00000188778 Adrenoceptor beta 3 8 37962991-37966965 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 ovary: 10.0;placenta: 4.1 gallbladder: 2.6 AGTR1 AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R ENSG00000144891 Angiotensin II receptor, type 1 3 148697784-148743008 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA003596 Supported Uncertain Vesicles Tissue enhanced 0 placenta: 212.0 liver: 50.8 AGTR2 AT2, MRX88 ENSG00000180772 Angiotensin II receptor, type 2 X 116170722-116174972 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 6 cervix, uterine: 6.8;endometrium: 13.8;fallopian tube: 3.8;lung: 12.6;smooth muscle: 17.4 adrenal gland: 1.9 APLNR AGTRL1, APJ, APJR, FLJ90771 ENSG00000134817 Apelin receptor 11 57233577-57237314 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB025842 Approved Group enriched 5 cerebral cortex: 82.9;placenta: 145.6;spleen: 164.2 adipose tissue: 24.9 AVPR1A AVPR1 ENSG00000166148 Arginine vasopressin receptor 1A 12 63142759-63150942 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 78.3 adipose tissue: 19.9 AVPR1B AVPR3 ENSG00000198049 Arginine vasopressin receptor 1B 1 206109692-206117699 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level No evidence Evidence at transcript level Not detected stomach: 0.3 AVPR2 DIR, DIR3, V2R ENSG00000126895 Arginine vasopressin receptor 2 X 153902531-153907166 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA046678 Approved Tissue enhanced 0 adipose tissue: 5.8 heart muscle: 2.8 BDKRB1 B1BKR, BKR1, bradyb1 ENSG00000100739 Bradykinin receptor B1 14 96255824-96268967 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA002935 Approved Tissue enhanced 0 gallbladder: 18.3;urinary bladder: 10.3 appendix: 7.0 BDKRB2 BK-2 ENSG00000168398 Bradykinin receptor B2 14 96204679-96244166 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA050841 Approved Mixed gallbladder: 32.6 BRS3 BB3 ENSG00000102239 Bombesin-like receptor 3 X 136487887-136493780 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 33 epididymis: 30.1 ovary: 0.9 C3AR1 AZ3B, C3AR ENSG00000171860 Complement component 3a receptor 1 12 8058302-8066471 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB009405 Supported Tissue enhanced 0 appendix: 88.4 placenta: 49.2 C5AR1 C5A, C5AR, C5R1, CD88 ENSG00000197405 Complement component 5a receptor 1 19 47290023-47322066 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB002720, HPA014520 Approved Tissue enhanced 0 appendix: 123.6 adipose tissue: 90.1 C5AR2 C5L2, GPR77 ENSG00000134830 Complement component 5a receptor 2 19 47332147-47347327 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA016629 Uncertain Tissue enhanced 0 spleen: 9.9 appendix: 6.1 CALCRL CGRPR, CRLR ENSG00000064989 Calcitonin receptor-like 2 187343129-187448460 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008070, HPA046515 Uncertain Supported Plasma membrane Tissue enhanced 0 lung: 114.4 adipose tissue: 76.3 CASR FHH, GPRC2A, HHC, HHC1, NSHPT ENSG00000036828 Calcium-sensing receptor 3 122183683-122286503 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA039686, HPA050335 Supported Tissue enriched 60 parathyroid gland: 1627.2 kidney: 27.0 CCKAR ENSG00000163394 Cholecystokinin A receptor 4 26481400-26490462 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 9 gallbladder: 47.3;stomach: 14.9 tonsil: 3.2 CCKBR ENSG00000110148 Cholecystokinin B receptor 11 6259736-6272127 Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 14 cerebral cortex: 13.7;pancreas: 5.4;stomach: 16.1 prostate: 0.8 CCR1 CD191, CKR-1, CMKBR1, MIP1aR, SCYAR1 ENSG00000163823 Chemokine (C-C motif) receptor 1 3 46201709-46208396 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 appendix: 58.8 spleen: 41.7 CCR10 GPR2 ENSG00000184451 Chemokine (C-C motif) receptor 10 17 42678889-42683917 Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB011684, HPA048007, HPA069188 Uncertain Supported Endoplasmic reticulum Mixed adipose tissue: 4.5 CCR2 CC-CKR-2, CD192, CKR2, CMKBR2, FLJ78302, MCP-1-R ENSG00000121807 Chemokine (C-C motif) receptor 2 3 46353734-46360928 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB003793 Approved Tissue enhanced 0 appendix: 53.0 spleen: 20.8 CCR3 CC-CKR-3, CD193, CKR3, CMKBR3 ENSG00000183625 Chemokine (C-C motif) receptor 3 3 46163604-46266706 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB003795 Uncertain Mixed small intestine: 3.0 CCR4 CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5 ENSG00000183813 Chemokine (C-C motif) receptor 4 3 32951574-32956349 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031613 Approved Tissue enhanced 0 appendix: 11.8 urinary bladder: 9.2 CCR5 CC-CKR-5, CD195, CKR-5, CKR5, CMKBR5, IDDM22 ENSG00000160791 Chemokine (C-C motif) receptor 5 (gene/pseudogene) 3 46370854-46376206 CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Mixed appendix: 20.9 CCR6 BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22 ENSG00000112486 Chemokine (C-C motif) receptor 6 6 167111807-167139696 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB006820, HPA014488 Approved Tissue enhanced 0 lymph node: 20.6;tonsil: 33.8 spleen: 17.3 CCR7 BLR2, CD197, CDw197, CMKBR7, EBI1 ENSG00000126353 Chemokine (C-C motif) receptor 7 17 40553769-40565472 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB003796, HPA031383, HPA074467 Supported Supported Mitochondria Group enriched 6 appendix: 91.9;lymph node: 98.3;spleen: 39.9;tonsil: 80.2 urinary bladder: 12.9 CCR8 CDw198, CKR-L1, CMKBR8, CMKBRL2, CY6, GPR-CY6, TER1 ENSG00000179934 Chemokine (C-C motif) receptor 8 3 39329706-39333511 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 urinary bladder: 2.4 appendix: 1.7 CCR9 CDw199, GPR-9-6, GPR28 ENSG00000173585 Chemokine (C-C motif) receptor 9 3 45886504-45903177 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB006839 Uncertain Group enriched 6 appendix: 1.5;duodenum: 3.9;small intestine: 5.8;spleen: 1.2 lymph node: 0.5 CCRL2 ACKR5, CKRX, CRAM-A, CRAM-B, HCR ENSG00000121797 Chemokine (C-C motif) receptor-like 2 3 46407163-46412997 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA043238 Approved Mixed lung: 17.7 CELSR1 ADGRC1, CDHF9, FMI2, HFMI2, ME2 ENSG00000075275 Cadherin, EGF LAG seven-pass G-type receptor 1 22 46360834-46537170 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA052976, HPA060521, HPA067269 Uncertain Supported Plasma membrane Mixed fallopian tube: 15.4 CELSR2 ADGRC2, CDHF10, EGFL2, Flamingo1, KIAA0279, MEGF3 ENSG00000143126 Cadherin, EGF LAG seven-pass G-type receptor 2 1 109250019-109275750 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013952 Uncertain Approved Cytosol Tissue enhanced 0 cerebral cortex: 45.2 skin: 31.1 CELSR3 ADGRC3, CDHF11, EGFL1, FMI1, HFMI1, MEGF2 ENSG00000008300 Cadherin, EGF LAG seven-pass G-type receptor 3 3 48636469-48662915 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA062866 Approved Group enriched 6 adrenal gland: 1.6;cerebral cortex: 6.0;testis: 3.6 parathyroid gland: 0.6 CHRM1 ENSG00000168539 Cholinergic receptor, muscarinic 1 11 62908679-62921807 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014101, CAB022366 Supported Approved Nucleus
Cytosol Group enriched 6 cerebral cortex: 40.0;prostate: 40.1;salivary gland: 11.1 breast: 4.7 CHRM2 ENSG00000181072 Cholinergic receptor, muscarinic 2 7 136868669-137020255 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022338, HPA029795 Approved Tissue enhanced 0 gallbladder: 18.4;heart muscle: 26.7;smooth muscle: 13.6 urinary bladder: 6.1 CHRM3 ENSG00000133019 Cholinergic receptor, muscarinic 3 1 239386565-239915452 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA024106, HPA048036 Approved Supported Plasma membrane Tissue enhanced 0 cerebral cortex: 15.7 esophagus: 8.5 CHRM4 ENSG00000180720 Cholinergic receptor, muscarinic 4 11 46385098-46386608 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level CAB022444, HPA072083 Uncertain Uncertain Nucleus
Golgi apparatus Tissue enhanced 0 cerebral cortex: 8.1;small intestine: 7.9;spleen: 21.9 testis: 6.9 CHRM5 ENSG00000184984 Cholinergic receptor, muscarinic 5 15 33968720-34067457 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA013172 Uncertain Tissue enhanced 0 cerebral cortex: 3.1;testis: 4.1 placenta: 2.5 CMKLR1 RVER1 ENSG00000174600 Chemerin chemokine-like receptor 1 12 108288044-108339341 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA047865 Uncertain Tissue enhanced 0 spleen: 49.3 placenta: 40.0 CNR1 CANN6, CB-R, CB1, CB1A, CB1K5, CNR ENSG00000118432 Cannabinoid receptor 1 (brain) 6 88139864-88166359 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB005603, HPA042256 Approved Approved Plasma membrane
Actin filaments Tissue enhanced 0 cerebral cortex: 32.2 adipose tissue: 12.1 CNR2 CB2 ENSG00000188822 Cannabinoid receptor 2 (macrophage) 1 23870526-23913362 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB009719 Uncertain Group enriched 7 appendix: 3.2;lymph node: 8.8;spleen: 8.1;tonsil: 7.2 bone marrow: 1.0 CRHR1 CRF-R, CRF1, CRHR ENSG00000120088 Corticotropin releasing hormone receptor 1 17 45784280-45835828 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 4.0 endometrium: 0.8 CRHR2 CRF-RB, CRF2, HM-CRF ENSG00000106113 Corticotropin releasing hormone receptor 2 7 30651943-30700129 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA046683 Uncertain Tissue enhanced 0 seminal vesicle: 1.8 cerebral cortex: 1.2 CX3CR1 CCRL1, CMKBRL1, CMKDR1, GPR13, V28 ENSG00000168329 Chemokine (C-X3-C motif) receptor 1 3 39263494-39281735 Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB032478, HPA046587 Approved Tissue enhanced 0 cerebral cortex: 59.4 spleen: 16.8 CXCR1 CD181, CDw128a, CKR-1, CMKAR1, IL8RA ENSG00000163464 Chemokine (C-X-C motif) receptor 1 2 218162845-218166995 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031991 Uncertain Tissue enhanced 0 appendix: 35.7;spleen: 25.4 adipose tissue: 15.5 CXCR2 CD182, CMKAR2, IL8RB ENSG00000180871 Chemokine (C-X-C motif) receptor 2 2 218125289-218137253 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016268, HPA031999, HPA032017 Supported Tissue enhanced 0 appendix: 56.9;spleen: 37.2 esophagus: 30.0 CXCR3 CD183, CKR-L2, CMKAR3, GPR9, IP10-R, MigR ENSG00000186810 Chemokine (C-X-C motif) receptor 3 X 71615916-71618517 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045942 Supported Tissue enhanced 0 lymph node: 18.1 spleen: 8.9 CXCR4 CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R ENSG00000121966 Chemokine (C-X-C motif) receptor 4 2 136114349-136118165 Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 bone marrow: 772.9 tonsil: 514.7 CXCR5 BLR1, CD185, MDR15 ENSG00000160683 Chemokine (C-X-C motif) receptor 5 11 118883766-118897799 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB026149, HPA042432 Supported Tissue enhanced 0 lymph node: 32.9;spleen: 21.7;tonsil: 16.2 appendix: 15.1 CXCR6 BONZO, CD186, STRL33, TYMSTR ENSG00000172215 Chemokine (C-X-C motif) receptor 6 3 45940933-45948353 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA047591 Uncertain Mixed lymph node: 17.6 CYSLTR1 CysLT(1), CysLT1, CYSLT1R ENSG00000173198 Cysteinyl leukotriene receptor 1 X 78271464-78327691 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA010546 Approved Mixed spleen: 15.1 CYSLTR2 CysLT(2), CYSLT2R ENSG00000152207 Cysteinyl leukotriene receptor 2 13 48653711-48711226 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA046528 Uncertain Tissue enhanced 0 placenta: 36.4;seminal vesicle: 24.8 spleen: 11.6 DRD1 ENSG00000184845 Dopamine receptor D1 5 175440039-175444208 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013393 Uncertain Tissue enhanced 0 cerebral cortex: 8.0 prostate: 1.6 DRD2 ENSG00000149295 Dopamine receptor D2 11 113409615-113475691 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA015691 Supported Tissue enriched 5 adrenal gland: 11.3 smooth muscle: 2.2 DRD3 ENSG00000151577 Dopamine receptor D3 3 114128652-114199407 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 13 testis: 1.3 lymph node: 0.1 DRD4 ENSG00000069696 Dopamine receptor D4 11 637293-640706 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected skin: 0.3 DRD5 DRD1B, DRD1L2 ENSG00000169676 Dopamine receptor D5 4 9781680-9784009 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA048930 Supported Tissue enhanced 0 appendix: 1.8;cerebral cortex: 2.0;stomach: 3.7 testis: 0.8 EDNRA ENSG00000151617 Endothelin receptor type A 4 147480917-147544954 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013774, CAB018957 Uncertain Tissue enhanced 0 seminal vesicle: 145.4 cervix: 82.6 EDNRB ETB, HSCR, HSCR2 ENSG00000136160 Endothelin receptor type B 13 77895481-77919768 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB017842, HPA027546 Approved Approved Plasma membrane
Cytosol Tissue enhanced 0 placenta: 178.8 cerebral cortex: 89.1 F2R CF2R, PAR-1, PAR1, TR ENSG00000181104 Coagulation factor II (thrombin) receptor 5 76716043-76735781 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB008973, CAB012962 Approved Expressed in all spleen: 95.4 F2RL1 GPR11, PAR2 ENSG00000164251 Coagulation factor II (thrombin) receptor-like 1 5 76818933-76835315 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB012989, HPA014091 Approved Approved Plasma membrane Mixed colon: 59.9 F2RL2 PAR3 ENSG00000164220 Coagulation factor II (thrombin) receptor-like 2 5 76615482-76623434 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 gallbladder: 10.9 smooth muscle: 5.6 F2RL3 PAR4 ENSG00000127533 Coagulation factor II (thrombin) receptor-like 3 19 16888860-16892606 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed thyroid gland: 7.8 FFAR1 FFA1R, GPR40 ENSG00000126266 Free fatty acid receptor 1 19 35351552-35353862 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 bone marrow: 1.9 ovary: 1.2 FFAR2 FFA2R, GPR43 ENSG00000126262 Free fatty acid receptor 2 19 35443907-35451767 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA023985 Approved Tissue enhanced 0 appendix: 26.2;bone marrow: 13.4 spleen: 11.1 FFAR3 FFA3R, GPR41 ENSG00000185897 Free fatty acid receptor 3 19 35358460-35360485 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA044681 Uncertain Tissue enhanced 0 adipose tissue: 2.5;appendix: 3.6;smooth muscle: 2.2 gallbladder: 0.8 FFAR4 GPR120, GPR129, O3FAR1, PGR4 ENSG00000186188 Free fatty acid receptor 4 10 93566665-93604480 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042563 Uncertain Uncertain Plasma membrane Tissue enhanced 0 colon: 8.6;rectum: 12.9 lung: 5.5 FPR1 FMLP, FPR ENSG00000171051 Formyl peptide receptor 1 19 51745172-51804110 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA046550, HPA061744 Approved Approved Nucleus
Nucleoli
Golgi apparatus Tissue enhanced 0 appendix: 181.6 bone marrow: 95.2 FPR2 ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R ENSG00000171049 Formyl peptide receptor 2 19 51752026-51770526 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA029154 Approved Tissue enhanced 0 appendix: 71.3 spleen: 20.0 FPR3 FMLPY, FPRH1, FPRL2, RMLP-R-I ENSG00000187474 Formyl peptide receptor 3 19 51795163-51826189 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Mixed lung: 41.3 FSHR FSHRO, LGR1, ODG1 ENSG00000170820 Follicle stimulating hormone receptor 2 48962157-49154537 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 9 ovary: 2.5;testis: 4.3 heart muscle: 0.3 FZD1 DKFZp564G072 ENSG00000157240 Frizzled class receptor 1 7 91264364-91271326 Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013008 Approved Supported Plasma membrane Mixed thyroid gland: 32.3 FZD10 CD350 ENSG00000111432 Frizzled class receptor 10 12 130162459-130165740 CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014484, HPA014485 Uncertain Supported Nucleoplasm Tissue enhanced 0 cervix, uterine: 9.3;esophagus: 8.8 skin: 5.6 FZD2 ENSG00000180340 Frizzled class receptor 2 17 44557459-44559570 Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA057667 Uncertain Approved Nuclear bodies
Cell Junctions Mixed placenta: 4.9 FZD3 ENSG00000104290 Frizzled class receptor 3 8 28494205-28574268 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB024995, HPA042320 Approved Approved Nucleoplasm
Vesicles Mixed cerebral cortex: 16.5 FZD4 CD344, EVR1 ENSG00000174804 Frizzled class receptor 4 11 86945679-86955391 CD markers, Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA042328, HPA074833 Approved Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 adipose tissue: 127.0 seminal vesicle: 42.1 FZD5 C2orf31, DKFZP434E2135, HFZ5 ENSG00000163251 Frizzled class receptor 5 2 207762586-207769563 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA052361 Approved Mixed duodenum: 20.1 FZD6 Hfz6 ENSG00000164930 Frizzled class receptor 6 8 103298433-103332866 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017991 Approved Approved Plasma membrane Mixed parathyroid gland: 45.3 FZD7 FzE3 ENSG00000155760 Frizzled class receptor 7 2 202034587-202038445 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA069165 Approved Nucleoplasm Mixed seminal vesicle: 38.7 FZD8 ENSG00000177283 Frizzled class receptor 8 10 35638249-35642278 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA045025, HPA071142 Approved Approved Endoplasmic reticulum Tissue enhanced 0 spleen: 16.2 lung: 6.6 FZD9 CD349, FZD3 ENSG00000188763 Frizzled class receptor 9 7 73433783-73436120 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 testis: 1.5 skeletal muscle: 1.5 GABBR1 GPRC3A, hGB1a ENSG00000204681 Gamma-aminobutyric acid (GABA) B receptor, 1 6 29555629-29633976 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050483, HPA058459 Uncertain Uncertain Centrosome Tissue enhanced 0 cerebral cortex: 20.9 spleen: 13.3 GABBR2 GABABR2, GPR51, GPRC3B, HG20 ENSG00000136928 Gamma-aminobutyric acid (GABA) B receptor, 2 9 98288082-98709197 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013820, HPA031684 Supported Tissue enriched 19 cerebral cortex: 88.4 adrenal gland: 4.6 GALR1 GALNR, GALNR1 ENSG00000166573 Galanin receptor 1 18 77250549-77277896 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 adrenal gland: 2.1;cerebral cortex: 1.7 testis: 0.5 GALR2 GALNR2 ENSG00000182687 Galanin receptor 2 17 76074794-76077541 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA044513 Approved Tissue enhanced 0 smooth muscle: 2.4 bone marrow: 0.6 GALR3 ENSG00000128310 Galanin receptor 3 22 37823382-37825495 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected cerebral cortex: 0.2 GCGR GGR ENSG00000215644 Glucagon receptor 17 81804132-81814013 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA071228 Approved Golgi apparatus Group enriched 7 adrenal gland: 6.6;kidney: 8.5;liver: 20.9;parathyroid gland: 9.4 skin: 1.6 GHRHR ENSG00000106128 Growth hormone releasing hormone receptor 7 30938669-30993254 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level No evidence Evidence at protein level Not detected adrenal gland: 0.5 GHSR ENSG00000121853 Growth hormone secretagogue receptor 3 172445133-172448456 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level CAB012451 Uncertain Not detected adrenal gland: 0.3 GIPR ENSG00000010310 Gastric inhibitory polypeptide receptor 19 45668244-45683724 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022710 Uncertain Tissue enhanced 0 stomach: 22.6 parathyroid gland: 12.2 GLP1R ENSG00000112164 Glucagon-like peptide 1 receptor 6 39048798-39087743 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 1.9;heart muscle: 1.8 pancreas: 1.5 GLP2R ENSG00000065325 Glucagon-like peptide 2 receptor 17 9822206-9892102 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level CAB022690, HPA049244 Supported Supported Plasma membrane Tissue enhanced 0 gallbladder: 19.4 duodenum: 10.4 GNRHR GRHR, LHRHR ENSG00000109163 Gonadotropin-releasing hormone receptor 4 67739328-67754360 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA013424 Supported Tissue enhanced 0 parathyroid gland: 1.2 adrenal gland: 1.0 GPBAR1 BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5 ENSG00000179921 G protein-coupled bile acid receptor 1 2 218259496-218263859 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062890 Approved Tissue enhanced 0 gallbladder: 27.0;smooth muscle: 13.8 adipose tissue: 10.0 GPER1 CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR ENSG00000164850 G protein-coupled estrogen receptor 1 7 1082208-1093815 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA027052 Approved Mixed placenta: 9.1 GPR1 ENSG00000183671 G protein-coupled receptor 1 2 206175316-206218047 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA010525 Uncertain Supported Vesicles
Plasma membrane Tissue enhanced 0 placenta: 11.2 esophagus: 5.5 GPR101 ENSG00000165370 G protein-coupled receptor 101 X 137030148-137031674 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Evidence at protein level HPA001084 Uncertain Not detected cerebral cortex: 0.1 GPR119 GPCR2, hGPCR2 ENSG00000147262 G protein-coupled receptor 119 X 130384440-130385447 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Not detected pancreas: 0.6 GPR12 GPCR21, PPP1R84 ENSG00000132975 G protein-coupled receptor 12 13 26755200-26760785 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA050972 Uncertain Tissue enhanced 0 cerebral cortex: 8.0 breast: 1.7 GPR132 G2A ENSG00000183484 G protein-coupled receptor 132 14 105049389-105065445 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA029694, HPA029695 Supported Mixed appendix: 9.7 GPR135 HUMNPIIY20, PAFR ENSG00000181619 G protein-coupled receptor 135 14 59429022-59465342 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA045337 Uncertain Tissue enhanced 0 testis: 9.1 fallopian tube: 5.0 GPR139 PGR3 ENSG00000180269 G protein-coupled receptor 139 16 20031485-20073917 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA046596 Uncertain Not detected endometrium: 0.3 GPR141 PGR13 ENSG00000187037 G protein-coupled receptor 141 7 37683796-37833788 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 bone marrow: 18.7 appendix: 5.8 GPR142 PGR2 ENSG00000257008 G protein-coupled receptor 142 17 74367407-74372622 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA031392 Uncertain Uncertain Plasma membrane
Cell Junctions
Cytosol Not detected appendix: 0.1 GPR143 OA1 ENSG00000101850 G protein-coupled receptor 143 X 9725346-9786297 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003648 Approved Mixed skin: 10.3 GPR146 PGR8 ENSG00000164849 G protein-coupled receptor 146 7 1044576-1059261 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Expressed in all adipose tissue: 35.4 GPR148 PGR6 ENSG00000173302 G protein-coupled receptor 148 2 130729070-130730336 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA060527 Uncertain Not detected stomach: 0.4 GPR149 IEDA, PGR10 ENSG00000174948 G protein-coupled receptor 149 3 154337672-154429715 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA018020 Uncertain Tissue enriched 6 seminal vesicle: 2.9 testis: 0.4 GPR15 ENSG00000154165 G protein-coupled receptor 15 3 98531899-98533150 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA013775 Approved Tissue enhanced 0 colon: 25.7;rectum: 47.8 urinary bladder: 19.1 GPR150 PGR11 ENSG00000178015 G protein-coupled receptor 150 5 95620078-95622142 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level No evidence HPA026635 Uncertain Tissue enhanced 0 cerebral cortex: 1.3;parathyroid gland: 2.0 pancreas: 1.0 GPR151 GALR4, PGR7 ENSG00000173250 G protein-coupled receptor 151 5 146513103-146516190 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected cerebral cortex: 0.2 GPR152 PGR5 ENSG00000175514 G protein-coupled receptor 152 11 67451301-67452729 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA035078 Uncertain Not detected parathyroid gland: 0.2 GPR153 PGR1 ENSG00000158292 G protein-coupled receptor 153 1 6247346-6260975 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007159 Approved Mixed cervix: 17.3 GPR156 GABABL, PGR28 ENSG00000175697 G protein-coupled receptor 156 3 120164645-120285094 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA028642, HPA028644 Uncertain Supported Plasma membrane Tissue enhanced 0 testis: 5.1 fallopian tube: 1.8 GPR157 FLJ12132 ENSG00000180758 G protein-coupled receptor 157 1 9100305-9129170 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA028697 Uncertain Uncertain Nucleoli
Plasma membrane
Cell Junctions Mixed parathyroid gland: 23.9 GPR158 KIAA1136 ENSG00000151025 G protein-coupled receptor 158 10 25175062-25602226 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA013185 Uncertain Approved Cytosol Tissue enriched 17 cerebral cortex: 17.9 testis: 1.0 GPR160 GPCR1, GPCR150 ENSG00000173890 G protein-coupled receptor 160 3 170037929-170085403 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA006970 Approved Supported Plasma membrane Tissue enhanced 0 parathyroid gland: 426.5 small intestine: 111.2 GPR161 RE2 ENSG00000143147 G protein-coupled receptor 161 1 168079543-168137667 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA015576, HPA072047 Uncertain Approved Nucleus
Nucleoli Tissue enhanced 0 smooth muscle: 39.8 endometrium: 28.5 GPR162 A-2, GRCA ENSG00000250510 G protein-coupled receptor 162 12 6821545-6829972 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA055135 Supported Approved Microtubule organizing center Group enriched 6 cerebral cortex: 84.5;fallopian tube: 29.1 lung: 9.6 GPR17 ENSG00000144230 G protein-coupled receptor 17 2 127645864-127652639 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA029766 Approved Approved Vesicles Mixed spleen: 12.3 GPR171 H963 ENSG00000174946 G protein-coupled receptor 171 3 151197832-151203201 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA062429 Approved Tissue enhanced 0 appendix: 30.7 lymph node: 21.8 GPR173 SREB3 ENSG00000184194 G protein-coupled receptor 173 X 53049091-53080615 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA003905 Approved Plasma membrane
Cytosol Tissue enhanced 0 cerebral cortex: 19.1 ovary: 9.0 GPR174 FKSG79 ENSG00000147138 G protein-coupled receptor 174 X 79170972-79172229 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA041025 Supported Uncertain Vesicles Tissue enhanced 0 lymph node: 30.2;spleen: 16.9;tonsil: 17.8 appendix: 13.1 GPR176 Gm1012 ENSG00000166073 G protein-coupled receptor 176 15 39799023-39920892 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA039943, HPA039979 Approved Mixed cerebral cortex: 19.1 GPR18 ENSG00000125245 G protein-coupled receptor 18 13 99254714-99261744 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA013873 Supported Tissue enhanced 0 lymph node: 52.2;testis: 25.1;tonsil: 32.9 appendix: 17.0 GPR182 ADMR, AM-R, G10D, hrhAMR ENSG00000166856 G protein-coupled receptor 182 12 56994446-56998441 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA027037 Supported Tissue enhanced 0 spleen: 12.4;testis: 6.6 liver: 2.0 GPR183 EBI2 ENSG00000169508 G protein-coupled receptor 183 13 99294530-99307405 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA028847, CAB033690 Uncertain Approved Nuclear membrane
Vesicles Mixed appendix: 117.8 GPR19 ENSG00000183150 G protein-coupled receptor 19 12 12660891-12696207 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA013955 Uncertain Tissue enhanced 0 cerebral cortex: 8.5;testis: 7.7 appendix: 2.8 GPR20 ENSG00000204882 G protein-coupled receptor 20 8 141356500-141367267 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Mixed smooth muscle: 1.2 GPR21 ENSG00000188394 G protein-coupled receptor 21 9 123034527-123035696 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA041651 Uncertain Tissue enhanced 0 cerebral cortex: 2.1 endometrium: 0.9 GPR22 ENSG00000172209 G protein-coupled receptor 22 7 107470018-107475659 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 13 adrenal gland: 2.4;cerebral cortex: 9.5;cervix, uterine: 6.3;endometrium: 5.0;heart muscle: 11.9 smooth muscle: 0.5 GPR25 ENSG00000170128 G protein-coupled receptor 25 1 200873038-200874123 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 stomach: 1.7 lung: 0.6 GPR26 ENSG00000154478 G protein-coupled receptor 26 10 123666355-123694607 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA062736 Supported Tissue enriched 15 cerebral cortex: 4.3 testis: 0.2 GPR27 SREB1 ENSG00000170837 G protein-coupled receptor 27 3 71754050-71756496 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA029395 Approved Approved Nucleoplasm
Plasma membrane
Actin filaments
Cytosol Tissue enhanced 0 parathyroid gland: 45.7 cerebral cortex: 24.9 GPR3 ACCA ENSG00000181773 G protein-coupled receptor 3 1 27392644-27395814 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB006254 Uncertain Tissue enhanced 0 cerebral cortex: 5.3 thyroid gland: 1.3 GPR31 12-HETER, HETER1 ENSG00000120436 G protein-coupled receptor 31 6 167156271-167158329 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014014, HPA027108 Uncertain Tissue enhanced 0 lymph node: 1.6 spleen: 0.9 GPR32 RVDR1 ENSG00000142511 G protein-coupled receptor 32 19 50770464-50771732 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA030330 Approved Tissue enriched 98 parathyroid gland: 254.8 placenta: 2.5 GPR33 ENSG00000214943 G protein-coupled receptor 33 (gene/pseudogene) 14 31482964-31487945 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected spleen: 0.4 GPR34 ENSG00000171659 G protein-coupled receptor 34 X 41688973-41697277 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA010668, CAB025490 Uncertain Uncertain Nucleus
Cytosol Mixed placenta: 60.4 GPR35 ENSG00000178623 G protein-coupled receptor 35 2 240605431-240631259 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 duodenum: 42.6;small intestine: 43.2 colon: 18.8 GPR37 EDNRBL, hET(B)R-LP, PAELR ENSG00000170775 G protein-coupled receptor 37 (endothelin receptor type B-like) 7 124745997-124765627 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042903, HPA068009 Approved Approved Nuclear membrane
Cytosol Tissue enhanced 0 cerebral cortex: 78.9;testis: 27.6 placenta: 12.7 GPR37L1 ETBR-LP-2 ENSG00000170075 G protein-coupled receptor 37 like 1 1 202122858-202133592 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA064454 Supported Tissue enriched 61 cerebral cortex: 34.2 seminal vesicle: 0.5 GPR39 ENSG00000183840 G protein-coupled receptor 39 2 132416574-132646559 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA022111 Approved Tissue enhanced 0 parathyroid gland: 17.7 colon: 6.2 GPR4 ENSG00000177464 G protein-coupled receptor 4 19 45589764-45602208 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA014278 Uncertain Mixed adipose tissue: 10.3 GPR42 FFAR3L, GPR41L, GPR42P ENSG00000126251 G protein-coupled receptor 42 (gene/pseudogene) 19 35370929-35372962 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level HPA044681 Uncertain Not detected small intestine: 0.3 GPR45 PSP24, PSP24A ENSG00000135973 G protein-coupled receptor 45 2 105241743-105243049 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055940 Uncertain Tissue enhanced 0 cerebral cortex: 1.8 testis: 0.5 GPR50 H9, Mel1c ENSG00000102195 G protein-coupled receptor 50 X 151176653-151181465 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA049862, HPA054678 Supported Supported Nucleoplasm
Plasma membrane Not detected placenta: 0.6 GPR52 ENSG00000203737 G protein-coupled receptor 52 1 174448111-174449198 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA028575 Uncertain Tissue enriched 7 cerebral cortex: 2.7 bone marrow: 0.3 GPR55 ENSG00000135898 G protein-coupled receptor 55 2 230907318-230961066 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 spleen: 5.9;testis: 9.0 tonsil: 4.6 GPR6 ENSG00000146360 G protein-coupled receptor 6 6 109978256-109980718 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 16 cerebral cortex: 1.5 epididymis: 0.0 GPR61 BALGR ENSG00000156097 G protein-coupled receptor 61 1 109539872-109548406 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007326, HPA026088 Approved Tissue enhanced 0 cerebral cortex: 3.4;thyroid gland: 1.2 adrenal gland: 1.0 GPR62 ENSG00000180929 G protein-coupled receptor 62 3 51955314-51957504 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enriched 13 cerebral cortex: 8.0 ovary: 0.6 GPR63 PSP24(beta), PSP24B ENSG00000112218 G protein-coupled receptor 63 6 96794126-96837463 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA039103 Approved Approved Nucleus
Plasma membrane
Cytosol Mixed testis: 4.6 GPR65 hTDAG8, TDAG8 ENSG00000140030 G protein-coupled receptor 65 14 88005124-88014811 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA054454 Approved Cytosol Mixed spleen: 13.5 GPR68 OGR1 ENSG00000119714 G protein-coupled receptor 68 14 91232532-91253925 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Mixed appendix: 8.4 GPR75 WI-31133 ENSG00000119737 G protein-coupled receptor 75 2 53852913-53859989 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 17.8 parathyroid gland: 6.4 GPR78 ENSG00000155269 G protein-coupled receptor 78 4 8558725-8619761 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013209 Uncertain Not detected adipose tissue: 0.0 GPR82 ENSG00000171657 G protein-coupled receptor 82 X 41724155-41730135 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA035914 Approved Tissue enhanced 0 tonsil: 6.7 lymph node: 3.7 GPR83 GPR72 ENSG00000123901 G protein-coupled receptor 83 11 94377311-94401419 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Group enriched 5 adrenal gland: 1.0;cerebral cortex: 4.6;thyroid gland: 5.2 epididymis: 0.6 GPR84 EX33 ENSG00000139572 G protein-coupled receptor 84 12 54362445-54364487 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA027603 Supported Tissue enhanced 0 appendix: 11.9;bone marrow: 14.7 adipose tissue: 5.9 GPR85 SREB2 ENSG00000164604 G protein-coupled receptor 85 7 113078331-113087778 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 16.8 skeletal muscle: 11.5 GPR87 GPR95 ENSG00000138271 G protein-coupled receptor 87 3 151294086-151316952 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA066313 Approved Nucleoplasm
Lipid droplets
Mitochondria Tissue enhanced 0 esophagus: 29.4;skin: 29.8 placenta: 11.9 GPR88 ENSG00000181656 G protein-coupled receptor 88 1 100538137-100542018 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007488 Uncertain Approved Group enriched 12 breast: 9.7;cerebral cortex: 3.1;liver: 5.1;ovary: 3.4;parathyroid gland: 7.9;spleen: 14.7 adipose tissue: 0.6 GPRC5A PEIG-1, RAI3, RAIG1, TIG1 ENSG00000013588 G protein-coupled receptor, class C, group 5, member A 12 12890782-12917937 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007928, HPA046526 Approved Validated Vesicles
Plasma membrane Tissue enhanced 0 lung: 302.3 thyroid gland: 90.7 GPRC5B RAIG-2 ENSG00000167191 G protein-coupled receptor, class C, group 5, member B 16 19856691-19886167 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA015247 Approved Supported Nucleus
Nucleoli
Vesicles Tissue enhanced 0 cerebral cortex: 309.2 testis: 66.5 GPRC5C RAIG-3 ENSG00000170412 G protein-coupled receptor, class C, group 5, member C 17 74424851-74451653 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029776 Supported Uncertain Nucleus
Microtubule organizing center
Cytosol Mixed thyroid gland: 103.7 GPRC5D ENSG00000111291 G protein-coupled receptor, class C, group 5, member D 12 12940775-12952147 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA071909 Approved Mixed testis: 5.2 GPRC6A bA86F4.3 ENSG00000173612 G protein-coupled receptor, class C, group 6, member A 6 116792085-116829037 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Not detected kidney: 0.7 GRM1 GPRC1A, mGlu1, MGLUR1, PPP1R85 ENSG00000152822 Glutamate receptor, metabotropic 1 6 146027646-146437598 Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA015701 Approved Approved Vesicles Tissue enhanced 0 cerebral cortex: 7.1 heart muscle: 1.4 GRM2 GPRC1B, mGlu2, MGLUR2 ENSG00000164082 Glutamate receptor, metabotropic 2 3 51707070-51718613 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA065166 Approved Tissue enriched 10 cerebral cortex: 4.4 testis: 0.4 GRM3 GPRC1C, mGlu3, MGLUR3 ENSG00000198822 Glutamate receptor, metabotropic 3 7 86643914-86864884 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 34 cerebral cortex: 62.5 testis: 1.8 GRM4 GPRC1D, mGlu4, MGLUR4 ENSG00000124493 Glutamate receptor, metabotropic 4 6 34018645-34155622 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level CAB022096 Supported Tissue enhanced 0 cerebral cortex: 2.9 testis: 0.7 GRM5 GPRC1E, mGlu5, MGLUR5, PPP1R86 ENSG00000168959 Glutamate receptor, metabotropic 5 11 88504576-89065945 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 9 cerebral cortex: 27.3 testis: 3.1 GRM6 CSNB1B, GPRC1F, mGlu6, MGLUR6 ENSG00000113262 Glutamate receptor, metabotropic 6 5 178978327-178996206 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014511 Supported Not detected testis: 0.8 GRM7 GLUR7, GPRC1G, mGlu7, MGLUR7, PPP1R87 ENSG00000196277 Glutamate receptor, metabotropic 7 3 6770001-7741533 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA015964 Uncertain Cytosol Tissue enhanced 0 cerebral cortex: 10.1;parathyroid gland: 7.0 smooth muscle: 3.4 GRM8 GLUR8, GPRC1H, mGlu8, MGLUR8 ENSG00000179603 Glutamate receptor, metabotropic 8 7 126438598-127253294 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051481 Uncertain Tissue enhanced 0 cerebral cortex: 4.1 testis: 2.9 GRPR BB2 ENSG00000126010 Gastrin-releasing peptide receptor X 16123556-16153021 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA069604 Validated Plasma membrane Tissue enhanced 0 pancreas: 4.2 breast: 2.6 HCAR1 FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR ENSG00000196917 Hydroxycarboxylic acid receptor 1 12 122726076-122730843 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 7 parathyroid gland: 113.5 breast: 15.1 HCAR2 GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG ENSG00000182782 Hydroxycarboxylic acid receptor 2 12 122701293-122703343 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA028660 Approved Approved Cell Junctions Tissue enhanced 0 spleen: 36.5 esophagus: 25.6 HCAR3 GPR109B, HCA3, HM74 ENSG00000255398 Hydroxycarboxylic acid receptor 3 12 122714756-122716892 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA028660 Approved Approved Cell Junctions Tissue enhanced 0 bone marrow: 16.7;spleen: 22.1 appendix: 12.6 HCRTR1 OX1R ENSG00000121764 Hypocretin (orexin) receptor 1 1 31617686-31632518 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014018 Approved Mixed adrenal gland: 1.2 HCRTR2 OX2R ENSG00000137252 Hypocretin (orexin) receptor 2 6 55106460-55282620 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA054516 Supported Not detected kidney: 0.6 HRH1 ENSG00000196639 Histamine receptor H1 3 11137093-11263557 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA029740 Uncertain Supported Plasma membrane
Cytosol Mixed cerebral cortex: 12.4 HRH2 ENSG00000113749 Histamine receptor H2 5 175658030-175686242 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA013770 Approved Tissue enhanced 0 bone marrow: 26.4 placenta: 17.9 HRH3 GPCR97 ENSG00000101180 Histamine receptor H3 20 62214970-62220267 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 17 cerebral cortex: 11.1 adrenal gland: 0.6 HRH4 AXOR35, GPCR105, GPRv53, H4R, HH4R ENSG00000134489 Histamine receptor H4 18 24460629-24479957 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA035009 Uncertain Not detected skin: 0.7 HTR1A 5-HT1A, ADRB2RL1, ADRBRL1 ENSG00000178394 5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled 5 63960356-63962507 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA018073 Uncertain Group enriched 10 cerebral cortex: 1.9;ovary: 3.9 testis: 0.2 HTR1B 5-HT1B, 5-HT1DB, HTR1D2, S12 ENSG00000135312 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled 6 77462205-77463464 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA028808 Approved Uncertain Plasma membrane Tissue enhanced 0 placenta: 13.7;stomach: 5.8 cerebral cortex: 2.8 HTR1D 5-HT1D, HT1DA, HTRL, RDC4 ENSG00000179546 5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled 1 23191895-23194729 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 8 duodenum: 9.7;gallbladder: 2.5;small intestine: 9.3 fallopian tube: 0.8 HTR1E 5-HT1E ENSG00000168830 5-hydroxytryptamine (serotonin) receptor 1E, G protein-coupled 6 86937306-87016683 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA004931 Approved Tissue enhanced 0 endometrium: 2.4;ovary: 4.9 cerebral cortex: 1.9 HTR1F 5-HT1F, HTR1EL ENSG00000179097 5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled 3 87990696-87993835 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA005555 Uncertain Tissue enhanced 0 placenta: 2.7 cerebral cortex: 1.0 HTR2A 5-HT2A, HTR2 ENSG00000102468 5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled 13 46831550-46897076 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014011 Supported Tissue enriched 8 cerebral cortex: 32.3 smooth muscle: 3.8 HTR2B 5-HT(2B), 5-HT2B ENSG00000135914 5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled 2 231108230-231125118 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level CAB011448, HPA012867, HPA063658 Approved Approved Nucleoplasm Tissue enhanced 0 cervix, uterine: 31.1;endometrium: 30.0;smooth muscle: 23.0 adrenal gland: 19.1 HTR2C 5-HT2C, 5HTR2C, HTR1C ENSG00000147246 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled X 114584078-114910061 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 5 cerebral cortex: 3.1 cervix: 0.5 HTR4 5-HT4 ENSG00000164270 5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled 5 148451032-148677235 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA040591 Approved Tissue enhanced 0 duodenum: 5.0;small intestine: 10.2 heart muscle: 3.5 HTR5A 5-HT5A ENSG00000157219 5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled 7 155070324-155085749 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB017467 Approved Tissue enriched 11 cerebral cortex: 8.6 testis: 0.7 HTR6 5-HT6, 5-HT6R ENSG00000158748 5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled 1 19665287-19679562 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Not detected cerebral cortex: 0.8 HTR7 5-HT7 ENSG00000148680 5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled 10 90740823-90857698 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, RAS pathway related proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB022708 Uncertain Supported Nuclear speckles
Plasma membrane
Cytosol Group enriched 8 parathyroid gland: 43.9;testis: 16.0 urinary bladder: 3.9 KISS1R AXOR12, GPR54, HOT7T175 ENSG00000116014 KISS1 receptor 19 917287-921015 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA071913 Supported Vesicles
Plasma membrane Tissue enriched 5 cerebral cortex: 1.2 placenta: 0.2 LGR4 GPR48 ENSG00000205213 Leucine-rich repeat containing G protein-coupled receptor 4 11 27365961-27472775 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA030267, HPA054350 Uncertain Approved Microtubule organizing center Expressed in all kidney: 55.7 LGR5 FEX, GPR49, GPR67, HG38 ENSG00000139292 Leucine-rich repeat containing G protein-coupled receptor 5 12 71439770-71586310 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA012530 Approved Tissue enhanced 0 fallopian tube: 26.3;placenta: 26.7 seminal vesicle: 9.7 LGR6 FLJ14471 ENSG00000133067 Leucine-rich repeat containing G protein-coupled receptor 6 1 202193901-202319781 G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA008556 Approved Approved Nucleoplasm
Plasma membrane Tissue enhanced 0 fallopian tube: 14.1 gallbladder: 9.6 LHCGR HHG, LCGR, LGR2, LHR, ULG5 ENSG00000138039 Luteinizing hormone/choriogonadotropin receptor 2 48686775-48755730 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009814 Uncertain Group enriched 5 adipose tissue: 1.3;adrenal gland: 1.1;ovary: 1.5;testis: 4.3;thyroid gland: 1.1 breast: 0.3 LPAR1 edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1 ENSG00000198121 Lysophosphatidic acid receptor 1 9 110873263-111038458 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA050667 Approved Nuclear speckles
Plasma membrane Mixed cervix: 90.9 LPAR2 EDG-4, EDG4, LPA2 ENSG00000064547 Lysophosphatidic acid receptor 2 19 19623668-19628930 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA019616 Approved Mixed testis: 40.7 LPAR3 Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3 ENSG00000171517 Lysophosphatidic acid receptor 3 1 84811602-84893213 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA013421 Uncertain Supported Plasma membrane Tissue enhanced 0 fallopian tube: 66.2 prostate: 21.5 LPAR4 GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9 ENSG00000147145 Lysophosphatidic acid receptor 4 X 78747709-78757094 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA054951, HPA055571 Uncertain Tissue enhanced 0 ovary: 4.5 cerebral cortex: 2.2 LPAR5 GPR92, GPR93, KPG_010, LPA5 ENSG00000184574 Lysophosphatidic acid receptor 5 12 6618835-6636447 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA013170 Approved Mixed tonsil: 11.0 LPAR6 P2RY5, P2Y5 ENSG00000139679 Lysophosphatidic acid receptor 6 13 48389567-48444704 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA028934, HPA076273 Approved Supported Vesicles
Plasma membrane Expressed in all placenta: 100.1 LTB4R BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7 ENSG00000213903 Leukotriene B4 receptor 14 24311450-24318036 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA003873 Approved Tissue enhanced 0 skin: 165.5 esophagus: 42.8 LTB4R2 BLT2, BLTR2, JULF2, NOP9 ENSG00000213906 Leukotriene B4 receptor 2 14 24305734-24312053 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level CAB022689, HPA029680, HPA072921 Uncertain Supported Nucleoplasm
Plasma membrane Tissue enhanced 0 skin: 40.6 spleen: 11.2 MAS1 ENSG00000130368 MAS1 proto-oncogene, G protein-coupled receptor 6 159906690-159916530 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013564 Uncertain Tissue enhanced 0 cerebral cortex: 1.8 cervix: 0.7 MAS1L dJ994E9.2, MAS-L, MRG ENSG00000204687 MAS1 proto-oncogene like, G protein-coupled receptor 6 29486697-29487956 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA017983 Uncertain Approved Nucleoplasm
Plasma membrane
Cytosol Tissue enhanced 0 cervix, uterine: 5.1 epididymis: 2.3 MC1R MSH-R ENSG00000258839 Melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) 16 89912119-89920977 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 testis: 12.8 skin: 6.0 MC2R ACTHR ENSG00000185231 Melanocortin 2 receptor (adrenocorticotropic hormone) 18 13882044-13915707 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 24 adrenal gland: 50.8 epididymis: 2.1 MC3R MC3 ENSG00000124089 Melanocortin 3 receptor 20 56248732-56249815 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected testis: 0.1 MC4R ENSG00000166603 Melanocortin 4 receptor 18 60371110-60372775 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA016719 Uncertain Group enriched 10 cerebral cortex: 3.0;fallopian tube: 5.0 epididymis: 0.4 MC5R ENSG00000176136 Melanocortin 5 receptor 18 13824155-13826743 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA042365 Uncertain Tissue enriched 6 epididymis: 3.0 testis: 0.5 MCHR1 GPR24, MCH1R, SLC1 ENSG00000128285 Melanin-concentrating hormone receptor 1 22 40678750-40682814 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 cerebral cortex: 8.6 ovary: 2.1 MCHR2 GPR145, MCH2, MCH2R, SLT ENSG00000152034 Melanin-concentrating hormone receptor 2 6 99919910-99994247 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Group enriched 53 cerebral cortex: 8.6;testis: 6.2 colon: 0.1 MLNR GPR38 ENSG00000102539 Motilin receptor 13 49220338-49222377 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 thyroid gland: 2.8 bone marrow: 0.8 MRGPRD mrgD ENSG00000172938 MAS-related GPR, member D 11 68980021-68980986 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA031346 Uncertain Not detected seminal vesicle: 0.4 MRGPRE GPR167, mrgE ENSG00000184350 MAS-related GPR, member E 11 3227698-3232386 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA046556 Uncertain Tissue enhanced 0 cervix, uterine: 1.0 spleen: 0.6 MRGPRF GPR140, GPR168, MGC21621, mrgF ENSG00000172935 MAS-related GPR, member F 11 69004395-69013409 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA028811 Approved Supported Nuclear membrane
Plasma membrane Mixed smooth muscle: 77.8 MRGPRG GPR169, mrgG ENSG00000182170 MAS-related GPR, member G 11 3217944-3218813 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA058909 Uncertain Tissue enriched 18 testis: 1.7 adipose tissue: 0.0 MRGPRX1 MRGX1 ENSG00000170255 MAS-related GPR, member X1 11 18933813-18939507 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected adipose tissue: 0.0 MRGPRX2 MRGX2 ENSG00000183695 MAS-related GPR, member X2 11 19054455-19060681 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA055220 Approved Tissue enhanced 0 breast: 1.2;skin: 1.2 cervix: 0.6 MRGPRX3 MRGX3 ENSG00000179826 MAS-related GPR, member X3 11 18120955-18138480 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 salivary gland: 1.3 testis: 0.9 MRGPRX4 MRGX4 ENSG00000179817 MAS-related GPR, member X4 11 18172837-18197348 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Not detected testis: 0.1 MTNR1A MEL-1A-R ENSG00000168412 Melatonin receptor 1A 4 186533655-186555567 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 kidney: 2.2;testis: 1.9 colon: 1.2 MTNR1B ENSG00000134640 Melatonin receptor 1B 11 92969720-92985066 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 placenta: 1.4 testis: 0.8 NMBR BB1 ENSG00000135577 Neuromedin B receptor 6 142058330-142088799 G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA026665 Supported Plasma membrane
Cytosol Group enriched 5 fallopian tube: 1.3;testis: 2.6 cerebral cortex: 0.3 NMUR1 FM-3, GPC-R, GPR66, NMU1R ENSG00000171596 Neuromedin U receptor 1 2 231523160-231530495 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA027895 Uncertain Mixed adipose tissue: 5.5 NMUR2 NMU2R ENSG00000132911 Neuromedin U receptor 2 5 152391532-152433368 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA045836 Approved Tissue enhanced 0 stomach: 1.1;testis: 2.2 thyroid gland: 0.9 NPBWR1 GPR7 ENSG00000183729 Neuropeptides B/W receptor 1 8 52938431-52941117 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Not detected cerebral cortex: 0.7 NPBWR2 GPR8 ENSG00000125522 Neuropeptides B/W receptor 2 20 64105820-64107171 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level Not detected cerebral cortex: 0.1 NPFFR1 GPR147, NPFF1R1, OT7T022 ENSG00000148734 Neuropeptide FF receptor 1 10 70247329-70283676 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA037521 Uncertain Tissue enhanced 0 testis: 2.1 lymph node: 0.8 NPFFR2 GPR74, NPFF2, NPGPR ENSG00000056291 Neuropeptide FF receptor 2 4 72031804-72148067 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA026825 Approved Plasma membrane
Actin filaments Tissue enhanced 0 placenta: 2.3;seminal vesicle: 4.5 epididymis: 1.1 NPSR1 GPR154, GPRA, PGR14 ENSG00000187258 Neuropeptide S receptor 1 7 34658239-34878332 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA007489 Supported Not detected stomach: 0.5 NPY1R NPYR ENSG00000164128 Neuropeptide Y receptor Y1 4 163323961-163344832 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA029903 Approved Nucleus
Mitochondria
Cytosol Tissue enhanced 0 spleen: 153.9 breast: 39.0 NPY2R ENSG00000185149 Neuropeptide Y receptor Y2 4 155208629-155217078 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 breast: 1.0;cerebral cortex: 1.7;testis: 1.0 rectum: 0.6 NPY4R PP1, PPYR1, Y4 ENSG00000204174 Neuropeptide Y receptor Y4 10 46461099-46465881 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA027863 Approved Tissue enhanced 0 colon: 9.0;rectum: 10.5 skin: 6.4 NPY5R NPYR5 ENSG00000164129 Neuropeptide Y receptor Y5 4 163343939-163351934 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 spleen: 12.5;testis: 9.6 adipose tissue: 7.6 NTSR1 NTR ENSG00000101188 Neurotensin receptor 1 (high affinity) 20 62708837-62762771 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050299 Supported Plasma membrane Not detected cerebral cortex: 0.5 NTSR2 NTR2 ENSG00000169006 Neurotensin receptor 2 2 11658178-11670164 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 25 cerebral cortex: 25.1 ovary: 1.0 OPN1LW CBBM, CBP, COD5, RCP ENSG00000102076 Opsin 1 (cone pigments), long-wave-sensitive X 154144224-154159032 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level Not detected testis: 0.1 OPN1MW CBBM, CBD, COD5, GCP, OPN1MW1 ENSG00000268221 Opsin 1 (cone pigments), medium-wave-sensitive X 154182596-154196135 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected appendix: 0.2 OPN1MW2 ENSG00000166160 Opsin 1 (cone pigments), medium-wave-sensitive 2 X 154219756-154233286 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected epididymis: 0.0 OPN1MW3 ENSG00000269433 Opsin 1 (cone pigments), medium-wave-sensitive 3 X 154257538-154271805 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected skin: 0.1 OPN1SW BCP, BOP, CBT ENSG00000128617 Opsin 1 (cone pigments), short-wave-sensitive 7 128772491-128775790 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013562, HPA014083 Supported Mixed smooth muscle: 14.7 OPN3 ECPN, encephalopsin, ERO, NMO-1, PPP1R116 ENSG00000054277 Opsin 3 1 241590102-241677376 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB013682, HPA064443 Uncertain Approved Nucleoplasm Tissue enhanced 0 placenta: 26.8 lung: 12.7 OPN4 melanopsin, MOP ENSG00000122375 Opsin 4 10 86654557-86666848 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA039147 Approved Tissue enhanced 0 cerebral cortex: 2.2;parathyroid gland: 1.4 skeletal muscle: 0.9 OPN5 dJ402H5.1, neuropsin, TMEM13 ENSG00000124818 Opsin 5 6 47781982-47832780 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA026084 Supported Tissue enriched 42 testis: 4.3 heart muscle: 0.1 OPRD1 ENSG00000116329 Opioid receptor, delta 1 1 28812142-28871267 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013744 Uncertain Tissue enhanced 0 cerebral cortex: 2.6 adrenal gland: 0.8 OPRK1 KOR, OPRK ENSG00000082556 Opioid receptor, kappa 1 8 53225716-53251697 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB022595 Uncertain Group enriched 7 cerebral cortex: 3.6;prostate: 3.2;testis: 1.8 skeletal muscle: 0.3 OPRL1 KOR-3, NOCIR, OOR, ORL1 ENSG00000125510 Opiate receptor-like 1 20 64080173-64100643 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 cerebral cortex: 12.3 testis: 4.8 OPRM1 MOR1 ENSG00000112038 Opioid receptor, mu 1 6 154010496-154246867 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA014509, HPA067435 Supported Supported Tissue enhanced 0 testis: 4.2 esophagus: 1.2 OXER1 GPCR, GPR170, TG1019 ENSG00000162881 Oxoeicosanoid (OXE) receptor 1 2 42762481-42764261 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA051433 Uncertain Mixed small intestine: 9.3 OXGR1 aKGR, GPR80, GPR99, P2RY15, P2Y15 ENSG00000165621 Oxoglutarate (alpha-ketoglutarate) receptor 1 13 96985719-96994730 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA067673 Supported Plasma membrane Mixed breast: 5.2 OXTR ENSG00000180914 Oxytocin receptor 3 8750408-8769628 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 11 breast: 65.6 fallopian tube: 6.0 P2RY1 P2Y1 ENSG00000169860 Purinergic receptor P2Y, G-protein coupled, 1 3 152834693-152841439 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015577 Approved Tissue enhanced 0 placenta: 33.7 esophagus: 20.0 P2RY10 P2Y10 ENSG00000078589 Purinergic receptor P2Y, G-protein coupled, 10 X 78945332-78961954 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA036757, HPA065766 Approved Tissue enhanced 0 lymph node: 33.5;spleen: 23.0;tonsil: 24.9 appendix: 20.1 P2RY11 P2Y11 ENSG00000244165 Purinergic receptor P2Y, G-protein coupled, 11 19 10111538-10115372 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level HPA014232 Approved Mixed lymph node: 7.3 P2RY12 HORK3, P2Y12, SP1999 ENSG00000169313 Purinergic receptor P2Y, G-protein coupled, 12 3 151337380-151384812 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013796, HPA014518 Supported Tissue enriched 6 cerebral cortex: 84.0 lymph node: 13.3 P2RY13 FKSG77, GPR86, GPR94, P2Y13 ENSG00000181631 Purinergic receptor P2Y, G-protein coupled, 13 3 151326312-151329548 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA049047 Supported Tissue enhanced 0 spleen: 51.9 appendix: 28.7 P2RY14 GPR105, KIAA0001 ENSG00000174944 Purinergic receptor P2Y, G-protein coupled, 14 3 151212117-151278467 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level CAB022646 Uncertain Tissue enhanced 0 placenta: 45.4 esophagus: 23.4 P2RY2 P2U ENSG00000175591 Purinergic receptor P2Y, G-protein coupled, 2 11 73218298-73236352 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level CAB022642 Uncertain Uncertain Cytosol Tissue enhanced 0 esophagus: 19.0 skeletal muscle: 14.9 P2RY4 NRU, P2P, P2Y4, UNR ENSG00000186912 Pyrimidinergic receptor P2Y, G-protein coupled, 4 X 70258170-70259764 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB022644 Uncertain Tissue enhanced 0 small intestine: 3.1 rectum: 0.6 P2RY6 P2Y6 ENSG00000171631 Pyrimidinergic receptor P2Y, G-protein coupled, 6 11 73264505-73298617 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB022740 Uncertain Tissue enhanced 0 placenta: 16.8;spleen: 36.2 appendix: 11.0 P2RY8 P2Y8 ENSG00000182162 Purinergic receptor P2Y, G-protein coupled, 8 X 1462572-1537107 Cancer-related genes, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003631 Supported Tissue enhanced 0 lymph node: 43.1 tonsil: 29.0 PRLHR GPR10, PrRPR ENSG00000119973 Prolactin releasing hormone receptor 10 118589989-118595699 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA039361 Supported Group enriched 7 adrenal gland: 6.5;cerebral cortex: 3.5;endometrium: 3.9;smooth muscle: 5.4 seminal vesicle: 0.7 PROKR1 GPR73, GPR73a, PKR1, ZAQ ENSG00000169618 Prokineticin receptor 1 2 68643589-68658247 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA029396 Uncertain Group enriched 8 adipose tissue: 1.7;adrenal gland: 1.4;epididymis: 4.3 testis: 0.3 PROKR2 dJ680N4.3, GPR73b, GPR73L1, GPRg2, KAL3, PKR2 ENSG00000101292 Prokineticin receptor 2 20 5302040-5314369 Disease related genes, G-protein coupled receptors, Plasma proteins, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA047281 Uncertain Tissue enhanced 0 cerebral cortex: 3.0 bone marrow: 0.8 PTAFR ENSG00000169403 Platelet-activating factor receptor 1 28147166-28193936 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA027543 Approved Supported Nucleoplasm
Vesicles
Plasma membrane Tissue enhanced 0 appendix: 42.1 bone marrow: 26.2 PTGDR DP, DP1, PTGDR1 ENSG00000168229 Prostaglandin D2 receptor (DP) 14 52267713-52276724 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 rectum: 8.7;spleen: 8.9 colon: 5.7 PTGDR2 CD294, CRTH2, DP2, GPR44 ENSG00000183134 Prostaglandin D2 receptor 2 11 60850940-60855971 CD markers, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA014259 Uncertain Tissue enhanced 0 small intestine: 7.3;stomach: 7.5 parathyroid gland: 5.3 PTGER1 EP1 ENSG00000160951 Prostaglandin E receptor 1 (subtype EP1), 42kDa 19 14472466-14475362 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 kidney: 2.9;spleen: 2.6 lung: 0.7 PTGER2 EP2 ENSG00000125384 Prostaglandin E receptor 2 (subtype EP2), 53kDa 14 52314305-52328606 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Mixed cervix: 27.3 PTGER3 EP3 ENSG00000050628 Prostaglandin E receptor 3 (subtype EP3) 1 70852353-71047808 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA010689 Uncertain Group enriched 7 adipose tissue: 58.5;endometrium: 114.7;kidney: 87.6;smooth muscle: 103.9 skin: 14.0 PTGER4 EP4 ENSG00000171522 Prostaglandin E receptor 4 (subtype EP4) 5 40679498-40693735 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA011226, HPA012756 Approved Expressed in all bone marrow: 48.1 PTGFR FP ENSG00000122420 Prostaglandin F receptor (FP) 1 78303884-78539749 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 endometrium: 30.3;smooth muscle: 25.4 urinary bladder: 13.3 PTGIR IP ENSG00000160013 Prostaglandin I2 (prostacyclin) receptor (IP) 19 46620468-46625118 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 lung: 14.0 appendix: 8.4 PTH1R PTHR, PTHR1 ENSG00000160801 Parathyroid hormone 1 receptor 3 46877746-46903799 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA007978 Approved Tissue enhanced 0 kidney: 158.5 adrenal gland: 36.8 PTH2R PTHR2 ENSG00000144407 Parathyroid hormone 2 receptor 2 208359714-208854503 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA010655 Approved Mixed bone marrow: 2.9 QRFPR GPR103 ENSG00000186867 Pyroglutamylated RFamide peptide receptor 4 121329312-121381059 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA014300 Uncertain Not detected heart muscle: 0.6 RGR RP44 ENSG00000148604 Retinal G protein coupled receptor 10 84245053-84259960 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 11 cerebral cortex: 16.1 epididymis: 1.4 RHO CSNBAD1, OPN2, RP4 ENSG00000163914 Rhodopsin 3 129528640-129535169 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013440, CAB022486 Supported Not detected cerebral cortex: 0.3 RRH peropsin ENSG00000180245 Retinal pigment epithelium-derived rhodopsin homolog 4 109827994-109844604 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Not detected cerebral cortex: 0.5 RXFP1 LGR7, RXFPR1 ENSG00000171509 Relaxin/insulin-like family peptide receptor 1 4 158315311-158653372 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA027067 Approved Tissue enhanced 0 cerebral cortex: 21.7;endometrium: 10.1 adrenal gland: 5.7 RXFP2 GPR106, GREAT, INSL3R, LGR8, RXFPR2 ENSG00000133105 Relaxin/insulin-like family peptide receptor 2 13 31739542-31803388 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Evidence at protein level Not detected endometrium: 0.8 RXFP3 GPCR135, RLN3R1, RXFPR3, SALPR ENSG00000182631 Relaxin/insulin-like family peptide receptor 3 5 33936386-33938237 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level HPA027833 Uncertain Not detected adrenal gland: 0.3 RXFP4 GPCR142, GPR100, RLN3R2, RXFPR4 ENSG00000173080 Relaxin/insulin-like family peptide receptor 4 1 155941710-155942949 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 colon: 2.2;duodenum: 1.4;rectum: 2.6 small intestine: 1.1 S1PR1 CD363, D1S3362, edg-1, EDG1 ENSG00000170989 Sphingosine-1-phosphate receptor 1 1 101236888-101241518 Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010104, HPA075568 Supported Supported Vesicles Expressed in all adipose tissue: 86.5 S1PR2 AGR16, EDG5, Gpcr13, H218 ENSG00000267534 Sphingosine-1-phosphate receptor 2 19 10221435-10231272 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA014307 Approved Tissue enhanced 0 placenta: 26.9 lymph node: 13.5 S1PR3 EDG-3, EDG3 ENSG00000213694 Sphingosine-1-phosphate receptor 3 9 88991447-89005010 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Mixed smooth muscle: 51.8 S1PR4 EDG6 ENSG00000125910 Sphingosine-1-phosphate receptor 4 19 3172346-3180332 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA060601, HPA067232 Uncertain Mitochondria Tissue enhanced 0 lymph node: 18.3;spleen: 27.0 appendix: 14.5 S1PR5 Edg-8, EDG8 ENSG00000180739 Sphingosine-1-phosphate receptor 5 19 10512742-10517931 FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA029683 Supported Tissue enhanced 0 cerebral cortex: 14.9;skin: 22.1 spleen: 12.2 SCTR ENSG00000080293 Secretin receptor 2 119439843-119525301 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA007269 Uncertain Tissue enhanced 0 duodenum: 27.4;lung: 13.0;pancreas: 14.3 stomach: 4.2 SMO FZD11, SMOH ENSG00000128602 Smoothened, frizzled class receptor 7 129188872-129213545 Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB011446 Approved Mixed ovary: 30.3 SPECC1L-ADORA2A ENSG00000258555 SPECC1L-ADORA2A readthrough (NMD candidate) 22 24270898-24442356 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 bone marrow: 15.0;lymph node: 15.2 appendix: 12.5 SSTR1 ENSG00000139874 Somatostatin receptor 1 14 38207999-38213067 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA031506 Approved Tissue enhanced 0 cerebral cortex: 13.6;duodenum: 14.6;stomach: 21.4 small intestine: 9.3 SSTR2 ENSG00000180616 Somatostatin receptor 2 17 73165012-73176633 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA007264 Uncertain Supported Cytosol Tissue enhanced 0 cerebral cortex: 22.9 spleen: 5.9 SSTR3 ENSG00000278195 Somatostatin receptor 3 22 37204238-37212322 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022647 Approved Tissue enhanced 0 testis: 10.9 cerebral cortex: 3.9 SSTR4 ENSG00000132671 Somatostatin receptor 4 20 23035386-23036812 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA064252 Uncertain Not detected cerebral cortex: 0.8 SSTR5 ENSG00000162009 Somatostatin receptor 5 16 1078781-1080142 FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level HPA066503 Supported Plasma membrane Tissue enhanced 0 adrenal gland: 1.2 heart muscle: 0.8 SUCNR1 GPR91 ENSG00000198829 Succinate receptor 1 3 151873643-151884619 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level CAB022745 Uncertain Tissue enhanced 0 kidney: 42.0 thyroid gland: 15.8 TAAR1 TA1, TAR1, TRAR1 ENSG00000146399 Trace amine associated receptor 1 6 132644984-132646003 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA055614 Approved Group enriched 17 fallopian tube: 2.2;stomach: 7.9 prostate: 0.2 TAAR2 GPR58 ENSG00000146378 Trace amine associated receptor 2 6 132617022-132624275 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected testis: 0.4 TAAR5 PNR ENSG00000135569 Trace amine associated receptor 5 6 132588673-132589686 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA051703 Uncertain Not detected epididymis: 0.0 TAAR6 TA4, TRAR4 ENSG00000146383 Trace amine associated receptor 6 6 132570322-132571359 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected kidney: 0.1 TAAR8 GPR102, TA5, TAR5, TRAR5 ENSG00000146385 Trace amine associated receptor 8 6 132552693-132553721 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected epididymis: 0.0 TAAR9 TA3, TAR3, TRAR3 ENSG00000237110 Trace amine associated receptor 9 (gene/pseudogene) 6 132538290-132539336 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected adipose tissue: 0.0 TACR1 NK1R, NKIR, SPR, TAC1R ENSG00000115353 Tachykinin receptor 1 2 75046463-75199700 FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA074573 Approved Tissue enhanced 0 cervix, uterine: 7.3 fallopian tube: 4.7 TACR2 NK2R, NKNAR, SKR, TAC2R ENSG00000075073 Tachykinin receptor 2 10 69403903-69416867 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 smooth muscle: 66.9 esophagus: 23.2 TACR3 NK3R ENSG00000169836 Tachykinin receptor 3 4 103586031-103719816 Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA009418 Uncertain Not detected cerebral cortex: 0.5 TAS1R1 GPR70, T1R1, TR1 ENSG00000173662 Taste receptor, type 1, member 1 1 6555181-6579757 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA034579, HPA034580 Approved Tissue enriched 7 testis: 4.2 skin: 0.5 TAS1R2 GPR71, T1R2, TR2 ENSG00000179002 Taste receptor, type 1, member 2 1 18839599-18859682 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level No evidence No evidence Evidence at protein level Not detected epididymis: 0.0 TAS1R3 T1R3 ENSG00000169962 Taste receptor, type 1, member 3 1 1331314-1335306 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA053439 Approved Group enriched 5 epididymis: 14.7;salivary gland: 3.3 appendix: 1.7 TAS2R1 T2R1, TRB7 ENSG00000169777 Taste receptor, type 2, member 1 5 9628997-9712378 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA051879 Uncertain Tissue enriched 41 testis: 13.2 fallopian tube: 0.3 TAS2R10 T2R10, TRB2 ENSG00000121318 Taste receptor, type 2, member 10 12 10825317-10826358 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected epididymis: 0.2 TAS2R13 T2R13, TRB3 ENSG00000212128 Taste receptor, type 2, member 13 12 10907926-10909562 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected epididymis: 0.0 TAS2R14 T2R14, TRB1 ENSG00000212127 Taste receptor, type 2, member 14 12 10937406-11171573 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Mixed epididymis: 1.2 TAS2R16 T2R16 ENSG00000128519 Taste receptor, type 2, member 16 7 122994704-122995700 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected epididymis: 0.0 TAS2R19 T2R19, T2R23, TAS2R23, TAS2R48 ENSG00000212124 Taste receptor, type 2, member 19 12 11021619-11022620 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level No evidence Evidence at transcript level Not detected ovary: 0.2 TAS2R20 T2R20, T2R56, TAS2R49 ENSG00000255837 Taste receptor, type 2, member 20 12 10996495-10997875 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected skin: 0.8 TAS2R3 T2R3 ENSG00000127362 Taste receptor, type 2, member 3 7 141764097-141765197 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected ovary: 0.5 TAS2R30 T2R30, TAS2R47 ENSG00000256188 Taste receptor, type 2, member 30 12 11132958-11134644 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected testis: 0.2 TAS2R31 T2R31, T2R53, TAS2R44 ENSG00000256436 Taste receptor, type 2, member 31 12 11030387-11031407 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected parathyroid gland: 0.3 TAS2R38 PTC, T2R61 ENSG00000257138 Taste receptor, type 2, member 38 7 141972631-141973773 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA043862, HPA054366 Uncertain Not detected rectum: 0.3 TAS2R39 ENSG00000236398 Taste receptor, type 2, member 39 7 143183419-143184435 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA053456, HPA060680 Uncertain Not detected adipose tissue: 0.0 TAS2R4 T2R4 ENSG00000127364 Taste receptor, type 2, member 4 7 141778442-141780819 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Mixed skin: 1.7 TAS2R40 GPR60 ENSG00000221937 Taste receptor, type 2, member 40 7 143222037-143223079 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level Tissue enhanced 0 appendix: 1.0 spleen: 0.3 TAS2R41 T2R59 ENSG00000221855 Taste receptor, type 2, member 41 7 143477873-143478796 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA057063 Uncertain Not detected adipose tissue: 0.0 TAS2R42 hT2R55, T2R24, T2R55, TAS2R55 ENSG00000186136 Taste receptor, type 2, member 42 12 11185993-11186937 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA036149 Uncertain Approved Nucleoplasm
Actin filaments
Focal adhesion sites Not detected epididymis: 0.0 TAS2R43 T2R52 ENSG00000255374 Taste receptor, type 2, member 43 12 11091287-11134244 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected adipose tissue: 0.0 TAS2R46 T2R54 ENSG00000226761 Taste receptor, type 2, member 46 12 11061365-11062294 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected adipose tissue: 0.0 TAS2R5 T2R5 ENSG00000127366 Taste receptor, type 2, member 5 7 141790217-141791367 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 skin: 5.0 epididymis: 3.3 TAS2R50 T2R51 ENSG00000212126 Taste receptor, type 2, member 50 12 10985913-10986912 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level Not detected adipose tissue: 0.0 TAS2R60 T2R60 ENSG00000185899 Taste receptor, type 2, member 60 7 143443453-143444409 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA030416 Uncertain Not detected parathyroid gland: 0.1 TAS2R7 T2R7, TRB4 ENSG00000121377 Taste receptor, type 2, member 7 12 10801532-10802627 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected epididymis: 0.0 TAS2R8 T2R8, TRB5 ENSG00000121314 Taste receptor, type 2, member 8 12 10806051-10807293 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected epididymis: 0.0 TAS2R9 T2R9, TRB6 ENSG00000121381 Taste receptor, type 2, member 9 12 10809137-10810168 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level No evidence Evidence at protein level Not detected epididymis: 0.0 TBXA2R ENSG00000006638 Thromboxane A2 receptor 19 3594506-3606840 Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA077366 Supported Nuclear speckles
Plasma membrane Mixed spleen: 5.3 TRHR ENSG00000174417 Thyrotropin-releasing hormone receptor 8 109086621-109119584 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level No evidence Evidence at protein level Not detected thyroid gland: 0.2 TSHR LGR3 ENSG00000165409 Thyroid stimulating hormone receptor 14 80954989-81146302 Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level CAB000473 Approved Tissue enriched 277 thyroid gland: 443.8 lymph node: 1.6 UTS2R GPR14 ENSG00000181408 Urotensin 2 receptor 17 82374230-82375586 G-protein coupled receptors, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enhanced 0 testis: 1.1;thyroid gland: 1.3 duodenum: 0.3 VIPR1 HVR1, RDC1, VPAC1, VPAC1R ENSG00000114812 Vasoactive intestinal peptide receptor 1 3 42489299-42537573 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA026777 Approved Tissue enhanced 0 lung: 60.0 duodenum: 35.4 VIPR2 VPAC2, VPAC2R ENSG00000106018 Vasoactive intestinal peptide receptor 2 7 159028175-159144957 G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA062707 Approved Tissue enhanced 0 seminal vesicle: 28.2 epididymis: 14.8 VN1R1 V1RL1, VNR19I1, ZVNH1, ZVNR1 ENSG00000178201 Vomeronasal 1 receptor 1 19 57454790-57457142 G-protein coupled receptors, Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA062209 Uncertain Nucleus
Vesicles Mixed epididymis: 2.8 VN1R2 V1RL2 ENSG00000196131 Vomeronasal 1 receptor 2 19 53258292-53261837 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA044551 Uncertain Mixed small intestine: 2.5 VN1R4 V1RL4 ENSG00000228567 Vomeronasal 1 receptor 4 19 53266676-53267723 G-protein coupled receptors, Predicted membrane proteins Evidence at transcript level No evidence Evidence at transcript level HPA027018 Uncertain Not detected testis: 0.5 XCR1 CCXCR1, GPR5 ENSG00000173578 Chemokine (C motif) receptor 1 3 46017024-46027742 G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins Evidence at protein level Evidence at transcript level Evidence at protein level HPA013169 Uncertain Tissue enhanced 0 lymph node: 11.0 spleen: 9.3